Skip navigation
HomeHomeHome
Home
Analytes/Measurements View

The Analytes/Measurements View lists the analytes (chemical entities) and the hearing measurements that serve as markers for newborn screening conditions. This view includes the analytes you selected on a previous screen, a short name, and a Logical Observation Identifiers Names and Codes (LOINC®) Number that may be used in electronic laboratory reports. Click on an analyte name to view related conditions, or to see answer lists for measurements with categorical values. For measurements with numeric values, the view also includes the units of measurement.

   
Analyte Name1
Choose analyte to view related conditions
Analyte
Short Name2
LOINC
Number3
Units4
Point of Care
 Hearing
   Newborn hearing screen - leftHear-L54108-6Answer list
   Newborn hearing screen - rightHear-R54109-4Answer list
   Newborn hearing screen methodHear-Meth54106-0Answer list
 Critical Congenital Heart Disease
   CCHD newborn screening protocol usedCCHD protocol73697-5 
   Difference between preductal and postductal saturationPre-post difference73696-7%
   Postductal (either foot) oxygen saturationPostductal O2 sat59418-4%
   Preductal (right hand) oxygen saturationPreductal O2 sat59407-7%
   CCHD newborn screening interpretation 73700-7Answer list
MS/MS
 Amino Acid
   5-Oxoproline+PipecolateOXOPRO + PIPA53232-5umol/L
   5-Oxoproline+Pipecolate/Phenylalanine[OXOPRO + PIPA] / PHE53394-3{ratio}
   Alanine+Beta Alanine+SarcosineALA + BALA + SARC53150-9umol/L
   Alloisoleucine+Isoleucine+Leucine+HydroxyprolineAILE + ILE + LEU + OHPRO53152-5umol/L
   Alloisoleucine+Isoleucine+Leucine+Hydroxyproline+Valine/Phenylalanine+Tyrosine[AILE + ILE + LEU + OHPRO + VAL] / [PHE + TYR]53393-5{ratio}
   Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Alanine[AILE + ILE + LEU + OHPRO] / ALA53154-1{ratio}
   Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Phenylalanine[AILE + ILE + LEU + OHPRO] / PHE53153-3{ratio}
   ArginineARG47562-4umol/L
   Arginine/OrnithineARG / ORN75214-7{ratio}
   Arginine/PhenylalanineARG / PHE53398-4{ratio}
   ArgininosuccinateASA53062-6umol/L
   Argininosuccinate/ArginineASA / ARG53200-2{ratio}
   Asparagine+OrnithineASN + ORN53155-8umol/L
   Asparagine+Ornithine/Phenylalanine[ASN + ORN] / PHE53396-8{ratio}
   Asparagine+Ornithine/Serine[ASN + ORN] / SER53395-0{ratio}
   AspartateASP47573-1umol/L
   CitrullineCIT42892-0umol/L
   Citrulline/ArginineCIT/ARG54092-2{ratio}
   Citrulline/PhenylalanineCIT / PHE53157-4{ratio}
   Citrulline/TyrosineCIT / TYR53399-2{ratio}
   GlutamateGLU47623-4umol/L
   GlycineGLY47633-3umol/L
   HistidineHIS47643-2umol/L
   HomocitrullineHOMOCIT53158-2umol/L
   LysineLYS47689-5umol/L
   MethionineMET47700-0umol/L
   Methionine/Alloisoleucine+Isoleucine+Leucine+HydroxyprolineMET / [AILE + ILE + LEU + OHPRO]53397-6{ratio}
   Methionine/PhenylalanineMET / PHE53156-6{ratio}
   Ornithine/CitrullineORN / CIT75215-4{ratio}
   PhenylalaninePHE29573-3umol/L
   Phenylalanine/TyrosinePHE / TYR35572-7{ratio}
   ProlinePRO47732-3umol/L
   Proline/PhenylalaninePRO / PHE53392-7{ratio}
   SerineSER47742-2umol/L
   SuccinylacetoneSUAC53231-7umol/L
   ThreonineTHR47784-4umol/L
   TryptophanTRP53159-0umol/L
   TyrosineTYR35571-9umol/L
   ValineVAL47799-2umol/L
   Valine/PhenylalanineVAL/PHE53151-7{ratio}
   Amino acidemias newborn screen interpretation 46733-2Answer list
 Fatty Acid Oxidation
   3-Hydroxybutyrylcarnitine (C4-OH)C4OH50102-3umol/L
   3-Hydroxydecenoylcarnitine (C10:1-OH)C10:1OH53182-2umol/L
   3-Hydroxydodecanoylcarnitine (C12-OH)C12OH53189-7umol/L
   3-Hydroxydodecenoylcarnitine (C12:1-OH)C12:1OH53188-9umol/L
   3-Hydroxyhexanoylcarnitine (C6-OH)C6OH53173-1umol/L
   3-Hydroxylinoleoylcarnitine (C18:2-OH)C18:2OH50109-8umol/L
   3-Hydroxyoleoylcarnitine (C18:1-OH)C18:1OH50113-0umol/L
   3-Hydroxypalmitoleylcarnitine (C16:1-OH)C16:1OH50121-3umol/L
   3-Hydroxypalmitoylcarnitine (C16-OH)C16OH50125-4umol/L
   3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16)C16OH / C1653201-0{ratio}
   3-Hydroxystearoylcarnitine (C18-OH)C18OH50132-0umol/L
   3-Hydroxytetradecadienoylcarnitine (C14:2-OH)C14:2OH53196-2umol/L
   3-Hydroxytetradecanoylcarnitine (C14-OH)C14OH50281-5umol/L
   3-Hydroxytetradecenoylcarnitine (C14:1-OH)C14:1OH53197-0umol/L
   ABCD1 gene mutation analysisABCD179568-2Answer list
   Carnitine free (C0)C038481-8umol/L
   Carnitine free (C0)/Palmitoylcarnitine (C16)C0 / C1653233-3{ratio}
   Carnitine free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18)C0 / [C16 + C18]53235-8{ratio}
   Carnitine free (C0)/Stearoylcarnitine (C18)C0 / C1853234-1{ratio}
   Carnitine.free (C0)+Acetylcarnitine (C2)+Propionylcarnitine (C3)+Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)+Stearoylcarnitine (C18)/Citrulline[C0 + C2 + C3 + C16 + C18:1 + C18] / CIT53236-6{ratio}
   Decadienoylcarnitine (C10:2)C10:253180-6umol/L
   Decanoylcarnitine (C10)C1045197-1umol/L
   Decenoylcarnitine (C10:1)C10:145198-9umol/L
   Dodecanoylcarnitine (C12)C1245199-7umol/L
   Dodecenoylcarnitine (C12:1)C12:145200-3umol/L
   Hexanoylcarnitine (C6)C645211-0umol/L
   Linoleoylcarnitine (C18:2)C18:245217-7umol/L
   Lysophosphatidylcholine (C26:0)C26:0-LPC79321-6umol/L
   Lysophosphatidylcholine (C26:0) - HPLCC26:0-LPC-HPLC79567-4umol/L
   Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10)C3DC / C1075212-1{ratio}
   Octanoylcarnitine (C8)C853175-6umol/L
   Octanoylcarnitine (C8)/Acetylcarnitine (C2)C8 / C253176-4{ratio}
   Octanoylcarnitine (C8)/Decanoylcarnitine (C10)C8 / C1053177-2{ratio}
   Octenoylcarnitine (C8:1)C8:153174-9umol/L
   Oleoylcarnitine (C18:1)C18:153202-8umol/L
   Palmitoleylcarnitine (C16:1)C16:153198-8umol/L
   Palmitoylcarnitine (C16)C1653199-6umol/L
   Propionylcarnitine (C3)+Palmitoylcarnitine (C16)C3 + C1675211-3umol/L
   Stearoylcarnitine (C18)C1853241-6umol/L
   Stearoylcarnitine (C18)/Propionylcarnitine (C3)C18 / C353400-8{ratio}
   Tetradecadienoylcarnitine (C14:2)C14:253190-5umol/L
   Tetradecanoylcarnitine (C14)C1453192-1umol/L
   Tetradecenoylcarnitine (C14:1)C14:153191-3umol/L
   Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2)C14:1 / C253193-9{ratio}
   Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1)C14:1 / C12:153194-7{ratio}
   Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16)C14:1 / C1653195-4{ratio}
   Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14)C14:1 / C1470159-9{ratio}
   Fatty acid oxidation defects newborn screen interpretation 46736-5Answer list
 Fatty Acid Oxidation-Organic Acid
   3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)C8OH + C3DC53178-0umol/L
   3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Butyrylcarnitine+Isobutyrylcarnitine (C4)C8OH + C3DC / C453402-4{ratio}
   3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10)C8OH + C3DC / C1053179-8{ratio}
   Acetylcarnitine (C2)C250157-7umol/L
   Butyrylcarnitine+Isobutyrylcarnitine (C4)C453166-5umol/L
   Butyrylcarnitine+Isobutyrylcarnitine (C4)/Acetylcarnitine (C2)C4 / C253167-3{ratio}
   Butyrylcarnitine+Isobutyrylcarnitine (C4)/Octanoylcarnitine (C8)C4 / C853169-9{ratio}
   Butyrylcarnitine+Isobutyrylcarnitine (C4)/Propionylcarnitine (C3)C4 / C353168-1{ratio}
   Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)C5DC + C10OH53183-0umol/L
   Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/3-Hydroxyisovalerylcarnitine (C5-OH)C5DC + C10OH / C5OH53184-8{ratio}
   Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4)C5DC + C10OH / C453403-2{ratio}
   Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Octanoylcarnitine (C8)C5DC + C10OH / C853185-5{ratio}
   Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Palmitoylcarnitine (C16)C5DC + C10OH / C1653186-3{ratio}
 Organic Acid
   3-Hydroxyisovalerylcarnitine (C5-OH)C5OH50106-4umol/L
   3-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0)C5OH / C053171-5{ratio}
   3-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8)C5OH / C853172-3{ratio}
   Acrylylcarnitine (C3:1)C3:153237-4umol/L
   FormiminoglutamateFIGLU53165-7umol/L
   Glutarylcarnitine (C5-DC)C5DC45207-8umol/L
   Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)C5DC + C6OH67710-4umol/L
   Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Octanoylcarnitine (C8)C5DC + C6OH / C867711-2{ratio}
   Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Palmitoylcarnitine (C16)C5DC + C6OH / C1667701-3{ratio}
   Glutarylcarnitine (C5-DC)/Malonylcarnitine (C3-DC)C5DC / C3DC75216-2{ratio}
   Isovalerylcarnitine+Methylbutyrylcarnitine (C5)C545216-9umol/L
   Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Acetylcarnitine (C2)C5 / C253239-0{ratio}
   Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Carnitine.free (C0)C5 / C053238-2{ratio}
   Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Octanoylcarnitine (C8)C5 / C853401-6{ratio}
   Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Propionylcarnitine (C3)C5 / C353240-8{ratio}
   Malonylcarnitine (C3-DC)C3DC54462-7umol/L
   Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)C3DC + C4OH67708-8umol/L
   Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Decanoylcarnitine (C10)[C3DC + C4OH] / C1075213-9{ratio}
   Methylglutarylcarnitine (C6-DC)C6DC53187-1umol/L
   Methylmalonylcarnitine (C4-DC)C4DC45222-7umol/L
   Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH)C4DC + C5OH67709-6umol/L
   Methylmalonylcarnitine (C4-DC)/3-Hydroxyisovalerylcarnitine (C5-OH)C4DC / C5OH53181-4{ratio}
   Propionylcarnitine (C3)C353160-8umol/L
   Propionylcarnitine (C3)/Acetylcarnitine (C2)C3 / C253163-2{ratio}
   Propionylcarnitine (C3)/Carnitine.free (C0)C3 / C053162-4{ratio}
   Propionylcarnitine (C3)/MethionineC3 / MET53161-6{ratio}
   Propionylcarnitine (C3)/Palmitoylcarnitine (C16)C3 / C1653164-0{ratio}
   Tiglylcarnitine (C5:1)C5:153170-7umol/L
   Organic acidemias newborn screen interpretation 46744-9Answer list
Non-MS/MS
 Biotinidase
   Biotinidase [Enzymatic activity/volume]BIO75217-0nmoL/mL/min
   Biotinidase [Presence]BIO (presence)38478-4{presence}
   Biotinidase deficiency newborn screen interpretation 46761-3Answer list
 Cystic Fibrosis
   CFTR gene mutations foundCFTR-Mut54083-1Specific alleles
   DNA sequencing of the CFTR geneCFTR-Seq Specific mutations
   Sweat chlorideSweat-Cl2077-6mmol/L
   Trypsinogen I FreeIRT48633-2ug/L
   Cystic fibrosis newborn screen interpretation 46769-6Answer list
 Endocrine Disorders
   11-Deoxycorticosterone11DOC53347-1ng/dL
   11-Deoxycortisol11DC53338-0ug/dL
   17-Hydroxyprogesterone17OHP38473-5ng/mL
   17-Hydroxyprogesterone+Androstenedione/Cortisol17OCHS+Androst/Cortis53336-4{ratio}
   21-Deoxycortisol21DC53341-4ug/dL
   AndrostenedioneAndrost53343-0ng/dL
   CortisolCortis53345-5ug/dL
   ThyrotropinTSH29575-8m[IU]/L
   Thyroxine (T4)T431144-9ug/dL
   Congenital adrenal hyperplasia newborn screen interpretation 46758-9Answer list
   Congenital hypothyroidism newborn screen interpretation 46762-1Answer list
 Galactosemia
   Enzyme NADPH5NADPH5 mg/dL
   GalactoseGalact54084-9mg/dL
   Galactose 1 phosphate uridyl transferaseGal1PUT DBS Ql33288-2N/A
   Galactose 1 phosphate uridyl transferaseGal1PUT DBS-cCnc42906-8U/g{Hb}
   Galactosemias newborn screen interpretation 46737-3Answer list
 Hemoglobin Disorders
   Fifth most predominant hemoglobin5th most predominant Hb DBS64121-7Answer list
   Fourth most predominant hemoglobin4th most predominant Hb DBS64120-9Answer list
   Hemoglobin A/Hemoglobin.total%Hb A54072-4%
   Hemoglobin Barts/Hemoglobin.total%Hb Bart's54069-0%
   Hemoglobin C/Hemoglobin.total%Hb C54073-2%
   Hemoglobin D/Hemoglobin.total%Hb D54070-8%
   Hemoglobin E/Hemoglobin.total%Hb E54071-6%
   Hemoglobin F/Hemoglobin.total%Hb F54074-0%
   Hemoglobin O - Arab/Hemoglobin.total%Hb O-ARAB54068-2%
   Hemoglobin S/Hemoglobin.total%Hb S56476-5%
   Hemoglobin observations newborn screening panelHb observations NBS pnl DBS64116-7 
   Hemoglobins that can be presumptively identified based on available controlsHb pres ID based on avail contr DBS64122-5Answer list
   Most predominant hemoglobinMost predominant Hb DBS64117-5Answer list
   Second most predominant hemoglobin2nd most predominant Hb DBS64118-3Answer list
   Third most predominant hemoglobin3rd most predominant Hb DBS64119-1Answer list
   Hemoglobin disorders newborn screen interpretation 46740-7Answer list
 Infectious Diseases
   HIV 1+2 IgG AbHIV IgG54086-4Pos or Neg
   Toxoplasma gondii IgG AbTox IgG54087-2Pos or Neg
   Toxoplasma gondii IgM AbTox IgM54088-0Pos or Neg
 Lysosomal Storage Disorders
   Acid alpha glucosidaseGAA55827-0umol/L/h
   Acid beta glucosidaseGBA55917-9umol/L/h
   Acid sphingomyelinaseASM62316-5umol/L/h
   Alpha galactosidase AGLA55908-8umol/L/h
   Alpha-L-iduronidase (IDUA)IDUA55909-6umol/h/L
   GalactocerebrosidaseGALC62310-8umol/L/h
   Mucopolysaccharidosis type I interpretationMPS I79564-1Answer list
 Other
   Glucose-6-Phosphate dehydrogenaseG6PD33287-4N/A
   T-cell receptor excision circleTREC62320-7{copies}

The above view reflects the criteria you selected on the previous screen.

The view includes derived measures.

Legend

1

Analyte Name — the chemical whose concentration is being measured by the Dried Blood Spot testing, or the newborn hearing screening method.

2

Analyte Short Name — an abbreviation for the analyte.

3

LOINC Number — the unique and permanent code assigned by the Logical Observation Identifiers Names and CodesExternal Web Site Policy (LOINC®) Committee to identify the test measurement. LOINC codes are unique for different test methods and different units of reporting to enable interoperability and comparison of results from different labs. LOINC is a U.S. government standard for electronic health information exchange of laboratory tests and other measurements in Interoperability Specifications produced by the Healthcare Information Technology Standards Panel (HITSP).

4

Units — what is being counted or measured, using the Unified Code for Units of MeasureExternal Web Site Policy (UCUM). Ratios whose units fully cancel each other are indicated by {Ratio}. UCUM is the US standard for reporting units in laboratory messages. Results that are not quantitative have either a link to the specific LOINC answer list for that analyte or appropriate text (such as "Pos or Neg" or "Specific alleles").